Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Integrated Care Systems

- PMLiVE

ABPI sets out UK life sciences industry’s priorities for government’s budget

The ABPI highlights four key areas where the budget could boost UK life sciences

- PMLiVE

ABPI publishes new prescribing support guide for healthcare professionals

The report will help pharmaceutical companies support high-quality healthcare

- PMLiVE

ABPI publishes manifesto for government to accelerate UK life sciences industry

The trade association has called on political parties to commit to three broad goals and requirements

- PMLiVE

New terms for UK medicines scheme send ‘mixed message’ to life sciences industry

Life sciences leaders have previously warned against changes to the statutory scheme

- PMLiVE

NHS and pharmaceutical industry partnerships to change millions of lives

The report highlights how UK ICSs and the pharmaceutical industry can work together

- PMLiVE

Landmark UK medicines deal to save NHS £14bn in medicine costs

The agreement will help provide lifesaving treatments and care for NHS patients

- PMLiVE

ABPI report shows improvement in UK industry clinical trial performance

The data showed a 15% increase in annual recruitment to UK industry clinical trials

- PMLiVE

FREE Live Webinar – Solving your patient recruitment & retention challenges – 15th November 2023

Join Innovative Trials and Avillion in this FREE webinar

Innovative Trials

- PMLiVE

A New Era in Patient Recruitment & Retention

Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention .

Innovative Trials

The Navigator – Revolutionize your patient recruitment and retention

Innovative Trials

- PMLiVE

Innovative Trials partner with Great Ormond Street Hospital Children’s Charity

The patient recruitment company has chosen their UK charity partner for 2022/2023

Innovative Trials

- PMLiVE

ABPI welcomes new NHS research guidance for integrated care systems

Included in the proposals are calls for a fixed rebate rate of 6.88% on all eligible NHS medicine sales to be paid by the industry

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links